Core Viewpoint - Harvard Bioscience, Inc. (NASDAQ:HBIO) is implementing a reverse stock split to increase its stock price and comply with Nasdaq's minimum bid price requirement [2][5]. Group 1: Reverse Stock Split Details - The reverse stock split will exchange every 10 shares for 1 share, taking effect on March 13, 2026, with trading post-split commencing on March 16, 2026 [3][5]. - This strategic move is aimed at stabilizing the stock's value and enhancing market appeal, as the current stock price is $0.55, having decreased by 3.68% [2][4]. Group 2: Market Performance - HBIO's stock has fluctuated between $0.54 and $0.57 today, with a 52-week high of $0.95 and a low of $0.28 [4]. - The company's market capitalization is approximately $24.6 million, with a trading volume of 313,998 shares [4][5].